Horizon Pharma, Inc.
HZNP announced today that it intends to offer and sell,
subject to market and other conditions, units in an underwritten
public offering, with each unit consisting of one share of its common
stock and a warrant to purchase 0.5 of a share of its common stock.
Horizon also expects to grant the underwriters a 30-day option to
purchase additional shares of its common stock and warrants to
purchase shares of its common stock to cover overallotments, if any.
All of the units in the offering are being offered by Horizon.
Cowen and Company, LLC, JMP Securities LLC and Stifel Nicolaus Weisel
are acting as joint book-running managers for the offering.
The securities described above are being offered by Horizon pursuant
to a shelf registration statement previously filed with and declared
effective by the Securities and Exchange Commission (the "SEC"). A
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in